Publication Name	World Journal of Gastroenterology
Manuscript ID	3018
Country	South Korea

Received	2013-04-02 20:28
Peer-Review Started	2013-04-04 17:18
To Make the First Decision	2013-05-02 09:03
Return for Revision	2013-05-17 18:32
Revised	2013-05-20 11:37
Second Decision	2013-08-06 08:34
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-08-06 11:42
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-09-16 21:43
Publish the Manuscript Online	2013-10-18 17:02

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Molecular targeted therapy for hepatocellular carcinoma: Current and future
Manuscript Source	Invited Manuscript
All Author List	Jung Woo Shin and Young-Hwa Chung
Funding Agency and Grant Number
Corresponding Author	Young-Hwa Chung, MD, PhD, Professor, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeongwon-gil, Songpa-gu, Seoul 138-736, South Korea. yhchung@amc.seoul.kr
Key Words	Hepatocellular carcinoma; Targeted therapy; Molecular agents; Sorafenib
Core Tip	Sorafenib is the first drug to prolong survival of patients with advanced hepatocellular carcinoma (HCC). This advance has shifted the paradigm of systemic treatment for HCC toward molecular targeted therapy. This review aims to summarize the efforts to target molecular components of the signaling pathways that are responsible for the development and progression of HCC and to discuss perspectives on the future direction of research.
Publish Date	2013-10-18 17:02
Citation	Shin JW, Chung YH. Molecular targeted therapy for hepatocellular carcinoma: Current and future. World J Gastroenterol 2013; 19(37): 6144-6155
URL	http://www.wjgnet.com/1007-9327/full/v19/i37/6144.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i37.6144

Full Article (PDF)	WJG-19-6144.pdf
Manuscript File	3018-Review.docx
Answering Reviewers	3018-Answering reviewers.pdf
Copyright License Agreement	3018-Copyright assignment.docx
Non-Native Speakers of English Editing Certificate	3018-Language certificate.pdf
Peer-review Report	3018-Peer review(s).pdf
Scientific Editor Work List	3018-Scientific editor work list.doc